Fred Ramsdell
Founder at Sonoma Biotherapeutics, Inc.
Profile
Fred Ramsdell is the founder of Sonoma Biotherapeutics, Inc. founded in 2019, where he holds the title of Chief Scientific Officer.
In 2014-2016, he worked as Vice President-Immunology at aTyr Pharma, Inc. Dr. Ramsdell holds a doctorate from the University of California, Los Angeles and an undergraduate degree from the University of California San Diego.
Fred Ramsdell active positions
| Companies | Position | Start |
|---|---|---|
Sonoma Biotherapeutics, Inc.
 Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Sonoma Biotherapeutics, Inc. provides research, development, and manufacturing capabilities in cell therapy and genetic engineering. The company was founded by Jeffrey A. Bluestone, Fred Ramsdell, Alexander Rudensky, and Qizhi Tang in 2019 and is headquartered in South San Francisco, CA. | Founder | 01/01/2019 |
Former positions of Fred Ramsdell
| Companies | Position | End |
|---|---|---|
| ATYR PHARMA, INC. | Corporate Officer/Principal | 01/12/2016 |
Training of Fred Ramsdell
| University of California, Los Angeles | Doctorate Degree |
| University of California San Diego | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Sonoma Biotherapeutics, Inc.
Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Sonoma Biotherapeutics, Inc. provides research, development, and manufacturing capabilities in cell therapy and genetic engineering. The company was founded by Jeffrey A. Bluestone, Fred Ramsdell, Alexander Rudensky, and Qizhi Tang in 2019 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Fred Ramsdell
